Jonathan Fauerbach | Head of R&D
LenioBio

Dr. Jonathan A. Fauerbach, PhD, MBA
Head of R&D, LenioBio GmbH Jonathan Fauerbach is Head of Research and Development at LenioBio, where he leads the advancement of ALiCE®, a next-generation eukaryotic cell-free protein expression platform designed to transform the pace and possibilities of modern biotechnology. His mission is to break long-standing barriers in protein expression, enabling researchers to move from digital designs to functional biologics faster than ever before, and opening new paths for vaccines and therapeutics once thought unattainable. With close to a decade of experience in biotech, Jonathan brings expertise in antibody-drug conjugates, protein engineering, and nanotechnology, combined with a strong background in strategic leadership. He is passionate about shaping the future of biomanufacturing, building high-performing teams, and fostering collaborations that accelerate scientific breakthroughs and bring life-changing medicines to patients worldwide. https://www.linkedin.com/in/jfauerbach/